Am J Clin Oncol

1. AMJAD MM, Rafique M, Hussain SF, Mustafa M, et al
   Clinical Outcomes of Sacituzumab Govitecan in Breast Cancer: A Systematic Review, Meta-Analysis, and GRADE Assessment of Randomized Evidence.
   Am J Clin Oncol. 2026 Sep 18. doi: 10.1097/COC.0000000000001369.
   

   >> Share

   
   

   
   Ann Oncol

2. LICATA L, Mariani M, Chiavassa A, Partridge AH, et al
   Navigating uncertainties and evidence gaps in adjuvant therapy for premenopausal women with HR+/HER2- breast cancer.
   Ann Oncol. 2026 Sep 17:S0923-7534(26)06645-7. doi: 10.1016/j.annonc.2026.
   

   >> Share

   
   

   
   Ann Surg Oncol

3. CHAMBERLAIN V, Holt LR, Shern TP, Gadd MA, et al
   Risk Stratification of Atypical Breast Lesions Diagnosed on Core Needle Biopsy: Toward Selective Surgical Excision.
   Ann Surg Oncol. 2026;33:9054-9062.
   

   >> Share

   
   
4. RANGEL MM, Singh P, Madrigrano A, Lillemoe HA, et al
   Taking Leave During Breast Surgical Oncology Fellowship: A National Evaluation of Policy and Practice.
   Ann Surg Oncol. 2026;33:8729-8735.
   

   >> Share

   
   
5. PARK KU, Sather BK, Shah A, Minami CA, et al
   Artificial Intelligence-Generated Electronic Medical Record Summarization in Breast Surgical Oncology.
   Ann Surg Oncol. 2026;33:9102-9109.
   

   >> Share

   
   
6. WURFBAIN LF, Tiels LM, van der Sangen MJC, Walstra CJEF, et al
   Patterns of Care and Follow-up of Patients with an Ipsilateral Breast Tumor Event After Breast-Conserving Surgery: A Multicenter Retrospective Cohort Study in the Netherlands.
   Ann Surg Oncol. 2026;33:9110-9120.
   

   >> Share

   
   
7. CONROY MM, Cortina CS, Kong AL
   ASO Author Reflections: Not all Asian American and Pacific Islander Breast Cancer is the Same: The Need for Routine Population Data Disaggregation.
   Ann Surg Oncol. 2026 Sep 14. doi: 10.1245/s10434-026-20574.
   

   >> Share

   
   
8. CONROY MM, Gaur KS, Rein LE, Szabo A, et al
   ASO Visual Abstract: A Population-Based Analysis of Breast Cancer Outcomes among Disaggregated Asian American and Pacific Islander Women.
   Ann Surg Oncol. 2026 Sep 17. doi: 10.1245/s10434-026-20589.
   

   >> Share

   
   
9. LUKAC S, Schaffler H, Leinert E, Reimer T, et al
   Real-World Clinical, Enviro-Logistical and Economic Implications of Sentinel Lymph Node Biopsy Omission in Early Breast Cancer.
   Ann Surg Oncol. 2026 Sep 18. doi: 10.1245/s10434-026-20545.
   

   >> Share

   
   
10. AMBURN T, Louie D, Schwartz S, McFarlane A, et al
    ASO Visual Abstract: Increased Axillary Nodal Metastasis in Breast Cancer Patients with Limited English Proficiency.
    Ann Surg Oncol. 2026 Sep 18. doi: 10.1245/s10434-026-20512.
    

    >> Share

    
    

    
    BMC Cancer

11. NAKADA K, Takada K, Gose A, Nishimoto M, et al
    Timing and clinical burden of febrile neutropenia and treatment discontinuation during neoadjuvant chemotherapy.
    BMC Cancer. 2026;26:1096.
    

    >> Share

    
    

    
    BMJ

12. LIMB M
    Breast cancer: Life extending drug is now available on NHS in England.
    BMJ. 2026;394:e100896.
    

    >> Share

    
    

    
    Br J Cancer

13. JAUNIAUX B, Harvie MN, Sperrin M, Astley SM, et al
    Early-adulthood body mass index, mammographic density and post-menopausal breast cancer risk: a mediation analysis.
    Br J Cancer. 2026 Sep 17. doi: 10.1038/s41416-026-03593.
    

    >> Share

    
    
14. SJOQUIST KM, Dobrovic A, Robledo KP, Nesic K, et al
    Olaparib in HR-deficient, metastatic triple-negative breast and platinum-sensitive relapsed ovarian cancers without germline mutations in BRCA1/2: phase 2 EMBRACE trial.
    Br J Cancer. 2026 Jul 8. doi: 10.1038/s41416-026-03535.
    

    >> Share

    
    

    
    Breast Cancer (Dove Med Press)

15. ZHANG P, Gu Y
    Evaluation of Diagnostic Accuracy of Combined Ultrasound Elastography and Magnetic Resonance Imaging in Breast Cancer.
    Breast Cancer (Dove Med Press). 2026;18:635995.
    

    >> Share

    
    

    
    Breast Cancer Res

16. SARAFIDIS M, Sifakis EG, Bergh J, Foukakis T, et al
    Development and validation of a machine learning clinicogenomic model to improve prognostic stratification in ER-positive/HER2-negative early breast cancer.
    Breast Cancer Res. 2026;28:156.
    

    >> Share

    
    
17. ZHANG Y, Li K, Zhang S, Yang H, et al
    Intraoperative NIR-II fluorescence guidance for precise tumor margin assessment and maximized tissue preservation in breast surgery.
    Breast Cancer Res. 2026;28:154.
    

    >> Share

    
    
18. ISHIGURO H, Miyoshi Y, Yasojima H, Watanabe J, et al
    E7389-LF as a first-line chemotherapy for patients with metastatic/advanced HER2-negative breast cancer: results from the phase 1 dose-expansion part of study 114.
    Breast Cancer Res. 2026;28:158.
    

    >> Share

    
    

    
    Breast Cancer Res Treat

19. REAGAN AM, Rutherford CR, Prathibha S, Levy BE, et al
    Trends in contralateral prophylactic mastectomy and genetic testing in the era of new society guidelines.
    Breast Cancer Res Treat. 2026;219:14.
    

    >> Share

    
    
20. LEE B, Santos B, McArthur H, LeVee A, et al
    Contemporary therapy for small node-negative triple-negative breast cancer: a retrospective cohort study.
    Breast Cancer Res Treat. 2026;219:15.
    

    >> Share

    
    
21. EISSA IR, Wang Y, Tanabe KK
    Integrin alpha2 (CD49b) blockade remodels the tumor immune microenvironment and enhances anti-PD-L1 therapy in 4T1 breast cancer model.
    Breast Cancer Res Treat. 2026;219:16.
    

    >> Share

    
    
22. SCHOCHTER F, Friedl TWP, Schaffler H, Meier-Stiegen F, et al
    Efficacy, safety and circulating tumor cell dynamics in patients treated with Eribulin for HER2-negative advanced breast cancer - results from the phase II DETECT IVb trial.
    Breast Cancer Res Treat. 2026;219:12.
    

    >> Share

    
    
23. SANJARI MOGHADDAM A, Deng Z, Sereika SM, Habib M, et al
    Metastatic phenotype and post-metastatic survival across HER2-0, HER2-low, and HER2-positive breast cancer.
    Breast Cancer Res Treat. 2026;219:11.
    

    >> Share

    
    
24. LI X, Lampson K, Liou KT, Li Y, et al
    Association between cumulative symptom burden and cognitive impairment among breast cancer survivors: a cross-sectional study.
    Breast Cancer Res Treat. 2026;219:13.
    

    >> Share

    
    

    
    Breast J

25. PANG L, Li Y, Wang Z
    Is Neoadjuvant Chemotherapy Necessary for Male Breast Cancer? A SEER-Based Population Study.
    Breast J. 2026;2026:e3718304.
    

    >> Share

    
    

    
    Cancer

26. LAWRENCE L
    FDA adds vepdegestrant to options for ER-positive, HER2-negative, ESR1-mutated advanced breast cancer.
    Cancer. 2026;132:e70554.
    

    >> Share

    
    

    
    Cancer Lett

27. ADELEYE K, Seagroves TN, Li W
    Therapeutic potential of colchicine-binding site inhibitors in breast cancer brain metastasis.
    Cancer Lett. 2026 Sep 15:218844. doi: 10.1016/j.canlet.2026.218844.
    

    >> Share

    
    

    
    Cancer Res

28. ELKHOLI IE, Foulkes WD
    Germline predisposition and the pattern of breast cancer metastasis.
    Cancer Res. 2026 Sep 15. doi: 10.1158/0008-5472.CAN-25-5788.
    

    >> Share

    
    

    
    Carcinogenesis

29. KUANG X, Li Z, Zhang FF, Romanos-Nanclares A, et al
    Ultra-Processed Foods and Breast Cancer: Epidemiology, Mechanisms, and Prognostic Implications.
    Carcinogenesis. 2026 Sep 15:bgag062. doi: 10.1093.
    

    >> Share

    
    
30. UPADHYAY M, Bastian AV, Cardaci TD, Kim M, et al
    Fueling Early Tumorigenesis: Interplay Between the Exposome, Obesity-Driven Metabolic Dysfunction and Early-Onset Colorectal and Breast Cancer.
    Carcinogenesis. 2026 Sep 15:bgag063. doi: 10.1093.
    

    >> Share

    
    

    
    Clin Breast Cancer

31. SCHMALZLE M, Radigan R, Patel D, Singh S, et al
    Selective Omission of Oncotype Dx Genomic Testing in Ultra-Low-Risk Luminal A Breast Cancer.
    Clin Breast Cancer. 2026;26:58-62.
    

    >> Share

    
    
32. WILLIAMS K, Lecroy K, Jin M, Skinner AE, et al
    Impact of Axillary Reverse Mapping on Non-lymphedema Functional Axillary Complications After Axillary Lymph Node Dissection for Breast Cancer.
    Clin Breast Cancer. 2026;26:63-69.
    

    >> Share

    
    
33. BOZKURT D, Gobut H
    Predictive Effect of the Er/Ki67 Ratio on Axillary Metastasis in Breast Cancer Patients.
    Clin Breast Cancer. 2026;26:70-76.
    

    >> Share

    
    
34. ARRARAS JI, Illarramendi JJ, Manterola A, de la Cruz S, et al
    Quality of Life in Long-Term Elderly Early-Stage Breast Cancer Survivors from Spain.
    Clin Breast Cancer. 2026;26:77-84.
    

    >> Share

    
    
35. BOZORGPOUR R, Sadrabadi MS
    Multimodal Deep Stacking of Clinical and Multiomics Data for Breast Cancer Prognosis Prediction.
    Clin Breast Cancer. 2026;26:85-96.
    

    >> Share

    
    
36. PIRES AC, Bergmann A, Resende C, Thuler LCS, et al
    Cancer in Young Women: Late-Stage Breast Cancer Registry Analysis of a 24-Year Nationwide Retrospective Cohort of 52,734 Patients in Brazil (CLARA Study).
    Clin Breast Cancer. 2026;26:129-133.
    

    >> Share

    
    

    
    Clin Exp Metastasis

37. GUO M, Xu B, Xu R, Miao Z, et al
    Bone marrow adipose tissue: fueling breast cancer bone metastasis via pro-tumor mechanisms and novel therapeutic targets.
    Clin Exp Metastasis. 2026;43:48.
    

    >> Share

    
    

    
    Clin Med Insights Oncol

38. LI R, Huangfu R, Lan H, Zhang C, et al
    Efficacy and Safety Ranking of HER2-Targeted TKIs in Advanced Breast Cancer: A Bayesian Network Meta-Analysis.
    Clin Med Insights Oncol. 2026;20:11795549261489524.
    

    >> Share

    
    

    
    Eur Radiol

39. PESAPANE F, Latronico A, Abbate F, Penco S, et al
    Evaluating cognitive biases in AI-assisted mammography interpretation: a simulation reader study of explainable AI across radiologist experience levels.
    Eur Radiol. 2026;36:7639-7650.
    

    >> Share

    
    
40. DWAN D, Lamb LR, Haver HL, Giess CS, et al
    Diagnostic accuracy of an artificial intelligence-based breast ultrasound tool in pregnant and lactating patients.
    Eur Radiol. 2026;36:7855-7863.
    

    >> Share

    
    
41. AMIR T, Lee CH, Hogan MP, Eskreis-Winkler S, et al
    Clinical significance of lesion conspicuity on contrast-enhanced mammography.
    Eur Radiol. 2026;36:7864-7873.
    

    >> Share

    
    
42. SOLIMAN BK, Refaat R, Khater HM, Basha MAA, et al
    Multiparametric MRI for non-mass enhancement breast lesions: a prospective diagnostic accuracy study.
    Eur Radiol. 2026;36:7828-7841.
    

    >> Share

    
    

    
    J Clin Oncol

43. PARSONS HA
    Can Biomarkers Effectively Guide Treatment Tailoring in Human Epidermal Growth Factor 2-Positive Early Breast Cancer?
    J Clin Oncol. 2026 Sep 15:JCO2601857. doi: 10.1200/JCO-26-01857.
    

    >> Share

    
    

    
    J Natl Cancer Inst

44. NJOR SH, Pedersen CU, Lynge E, Smith RA, et al
    Breast cancer overdiagnosis in mammography trials-separating signal from noise: a meta-analysis.
    J Natl Cancer Inst. 2026 Sep 14:djag302. doi: 10.1093.
    

    >> Share

    
    
45. PIMENTEL-PARRA GA, Escalada-Hernandez P, San Martin-Rodriguez L, Garcia-Vivar C, et al
    Effectiveness of an eHealth intervention to improve quality of life in long-term breast cancer survivors: a 9-month randomized controlled trial.
    J Natl Cancer Inst. 2026 Sep 16:djag328. doi: 10.1093.
    

    >> Share

    
    

    
    J Surg Oncol

46. TOMALA J, Upadhyay N
    Comparative Analysis of CEM and Breast MRI: A Retrospective Study.
    J Surg Oncol. 2026;134:518-524.
    

    >> Share

    
    
47. CORSO G, Vecchia C, Magnoni F, Polizzi A, et al
    Bilateral Prophylactic and Contralateral Risk-Reducing Mastectomy in Women With Germline CDH1 Pathogenic or Likely-Pathogenic Variants.
    J Surg Oncol. 2026;134:475-480.
    

    >> Share

    
    
48. WAPNIR I, Allison KH, Pittman SM, Tsai J, et al
    Breast Fellows Forum: A Multidisciplinary Core Curriculum Model for Surgical Oncology Fellowships.
    J Surg Oncol. 2026;134:502-504.
    

    >> Share

    
    
49. CHEN J, Gabay A, Hassan AM, Graziano FD, et al
    AI Risk Prediction Tools for Autologous Breast Reconstruction.
    J Surg Oncol. 2026;134:539-547.
    

    >> Share

    
    

    
    Mod Pathol

50. RAKHA EA, Quinn C, Farshid G, Shaaban AM, et al
    Margin Adequacy in Phyllodes Tumors Revisited: Reappraisal of the Evidence Base and Knowledge Gaps.
    Mod Pathol. 2026;39:101034.
    

    >> Share

    
    
51. RIGGI JAM, Galant C, Bouzin C, Daumerie A, et al
    An Immunohistochemistry-based Decision Flowchart to De-escalate Axillary Surgery for Biopsy-Diagnosed Pure Ductal Carcinoma In Situ (DCIS) of the Breast.
    Mod Pathol. 2026;39:101040.
    

    >> Share

    
    

    
    Nature

52. WENCKSTERN J, Jain E, von Querfurth B, Cheng Y, et al
    The Virtual Tissues foundation model resolves spatial proteomics across scales.
    Nature. 2026;657:744-754.
    

    >> Share

    
    

    
    Oncol Rep

53. JIN H, Jeon KH, Kang C, Lee J, et al
    Pemetrexed increases BRCA1 protein stability and sensitizes TNBC cells to radiotherapy.
    Oncol Rep. 2026;56:188.
    

    >> Share

    
    

    
    PLoS One

54. MALHERBE K, Benn CA, Botha G
    Multi-site observational evaluation of Breast AI-supported ultrasound risk stratification in breast cancer assessment pathways.
    PLoS One. 2026;21:e0357975.
    

    >> Share

    
    
55. PAQUETTE B, Therriault H, Gauthier I, Provencher S, et al
    Role of Rab4A in the enhancement of cancer cell invasion induced by plasma samples collected during radiotherapy in patients with triple-negative breast cancer.
    PLoS One. 2026;21:e0329717.
    

    >> Share

    
    
56. SALIM EA, Ji X, Tarpley M, Dixon MS, et al
    From in silico prediction to experimental validation: Identification of drugs and novel synergistic combinations that inhibit growth of inflammatory breast cancer cells.
    PLoS One. 2026;21:e0339543.
    

    >> Share

    
    
57. YILMAZ BOZOK Y, Acar N, Atahan MK, Karaali C, et al
    Comparative evaluation of ChatGPT and gemini responses to patient-oriented questions on breast cancer.
    PLoS One. 2026;21:e0358325.
    

    >> Share

    
    
58. ZHOU Y, Gong J, Shen L, Ling J, et al
    Safety of eribulin: A real-world study based on a pharmacovigilance database.
    PLoS One. 2026;21:e0356800.
    

    >> Share

    
    
59. WU M, Wang J
    A segmentation-guided CNN-Vision transformer feature fusion framework for multi-class breast ultrasound image classification.
    PLoS One. 2026;21:e0353628.
    

    >> Share

    
    
60. ZENG H, Lu Y, Zhao Q, Gong J, et al
    Illness uncertainty in individuals with gynecologic and breast cancer: A latent profile analysis and structural equation modeling.
    PLoS One. 2026;21:e0358366.
    

    >> Share

    
    
61. XAVIER SP, Victor A, Gotine AREM, de Albuquerque Maia FH, et al
    Machine learning for predicting mortality in women diagnosed with breast cancer in the State of Mato Grosso, Brazil using linked population-based cancer registry and mortality data.
    PLoS One. 2026;21:e0356621.
    

    >> Share

    
    

    
    Proc Natl Acad Sci U S A

62. WU S, Chen S, Liu B, Liu Y, et al
    RHAMM drives formation of polyploid cancer cells and confers resistance to ER-targeted therapy in breast cancer.
    Proc Natl Acad Sci U S A. 2026;123:e2535342123.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share